Champ 6 - pharmacologie des agents utilisés dans l’état de mal épileptique

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Réanimation

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1016/J.REAURG.2008.09.024
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Valproic Acid Is Not a Substrate for P-glycoprotein or Multidrug Resistance Proteins 1 and 2 in a Number of in Vitro and in Vivo Transport Assays

  2007cited by this paper
• Pharmacokinetics and Therapeutic Drug Monitoring of Newer Antiepileptic Drugs During Pregnancy and the Puerperium

  2007cited by this paper
• The Role of Pharmacogenetics in the Metabolism of Antiepileptic Drugs

  2007cited by this paper
• Differences in the transport of the antiepileptic drugs phenytoin, levetiracetam and carbamazepine by human and mouse P-glycoprotein.

  2007cited by this paper
• Population Estimation of the Effects of Cytochrome P450 2C9 and 2C19 Polymorphisms on Phenobarbital Clearance in Japanese

  2007cited by this paper
• Various Pharmacogenetic Aspects of Antiepileptic Drug Therapy

  2007cited by this paper
• Levetiracetam Intravenous Infusion: A Randomized, Placebo‐controlled Safety and Pharmacokinetic Study

  2006cited by this paper
• Optimizing therapy of seizures in women who use oral contraceptives

  2006cited by this paper
• Valproic Acid in Epilepsy

  2006cited by this paper
• Effect of the UGT2B15 Genotype on the Pharmacokinetics, Pharmacodynamics, and Drug Interactions of Intravenous Lorazepam in Healthy Volunteers

  2005cited by this paper
• Variations on an inhibitory theme: phasic and tonic activation of GABAA receptors

  2005cited by this paper
• Estimation of population pharmacokinetic parameters of free-phenytoin in adult epileptic patients.

  2005cited by this paper
• Pharmacokinetic and Metabolic Investigation of Topiramate Disposition in Healthy Subjects in the Absence and in the Presence of Enzyme Induction by Carbamazepine

  2005cited by this paper
• Plasma and whole blood pharmacokinetics of topiramate: the role of carbonic anhydrase.

  2005cited by this paper
• Topiramate Pharmacokinetics in Children and Adults with Epilepsy

  2005cited by this paper
• Dissociated effects of diazepam and lorazepam on short‐latency afferent inhibition

  2005cited by this paper
• The neurobiology of antiepileptic drugs

  2004cited by this paper
• The Binding of Selected Therapeutic Drugs to Human Serum &agr;-1 Acid Glycoprotein and to Human Serum Albumin In Vitro

  2004cited by this paper
• Pharmacogenetics and enzyme induction/inhibition properties of antiepileptic drugs

  2004cited by this paper
• Estimation of the Plasma Effect Site Equilibration Rate Constant (ke0) of Propofol in Children Using the Time to Peak Effect: Comparison with Adults

  2004cited by this paper
• Clinical Pharmacokinetics of Levetiracetam

  2004cited by this paper
• Studies of phenytoin binding to human serum albumin by high-performance affinity chromatography.

  2004cited by this paper
• Pharmacokinetics and clinical effects of phenytoin and fosphenytoin in children with severe malaria and status epilepticus.

  2003cited by this paper
• Fosphenytoin

  2003cited by this paper
• Comparative population pharmacokinetics of lorazepam and midazolam during long-term continuous infusion in critically ill patients.

  2003cited by this paper
• Differential interaction of anaesthetics and antiepileptic drugs with neuronal Na+ channels, Ca2+ channels, and GABA(A) receptors.

  2003cited by this paper
• Using the Time of Maximum Effect Site Concentration to Combine Pharmacokinetics and Pharmacodynamics

  2003cited by this paper
• Sevoflurane is epileptogenic in healthy subjects at surgical levels of anesthesia

  2003cited by this paper
• The use of topiramate in refractory status epilepticus

  2003cited by this paper
• Propofol: a review of its use in intensive care sedation of adults.

  2003cited by this paper
• Clinically important drug interactions in epilepsy: interactions between antiepileptic drugs and other drugs.

  2003cited by this paper
• Free and bound propofol concentrations in human cerebrospinal fluid.

  2003cited by this paper
• P-Glycoprotein-mediated efflux of phenobarbital, lamotrigine, and felbamate at the blood-brain barrier: evidence from microdialysis experiments in rats.

  2002cited by this paper
• Role of multidrug transporters in pharmacoresistance to antiepileptic drugs.

  2002cited by this paper
• Drug resistance in epilepsy: expression of drug resistance proteins in common causes of refractory epilepsy.

  2002cited by this paper
• Population pharmacokinetic and pharmacodynamic modeling of propofol for long‐term sedation in critically ill patients: A comparison between propofol 6% and propofol 1%

  2002cited by this paper
• Pharmacological and Therapeutic Properties of Valproate

  2002cited by this paper
• Continuum solvent model studies of the interactions of an anticonvulsant drug with a lipid bilayer.

  2001cited by this paper
• The mechanisms of action of commonly used antiepileptic drugs.

  2001cited by this paper
• Pharmacokinetic and Pharmacodynamic Analysis of Sedative and Amnesic Effects of Lorazepam in Healthy Volunteers

  2001cited by this paper
• Therapeutic drug monitoring--antiepileptic drugs.

  2001cited by this paper
• Vagal Nerve Stimulation for Status epilepticus

  2001cited by this paper
• Plasma Concentration of Topiramate Correlates With Cerebrospinal Fluid Concentration

  2001cited by this paper
• Long-term propofol infusion and cardiac failure in adult head-injured patients.

  2001cited by this paper
• Pharmacokinetic profile of levetiracetam: toward ideal characteristics.

  2000cited by this paper
• Propofol in anesthesia. Mechanism of action, structure-activity relationships, and drug delivery.

  2000cited by this paper
• Kinetics and dynamics of lorazepam during and after continuous intravenous infusion

  2000cited by this paper
• Population Pharmacokinetics of Propofol: A Multicenter Study

  2000cited by this paper
• Pharmacokinetic Optimisation of Benzodiazepine Therapy for Acute Seizures

  1999cited by this paper
• Population estimation of valproic acid clearance in adult patients using routine clinical pharmacokinetic data

  1999cited by this paper
• Propofol-infusion syndrome in children.

  1999cited by this paper
• Brain Mechanisms of Propofol-Induced Loss of Consciousness in Humans: a Positron Emission Tomographic Study

  1999cited by this paper
• Binding of propofol to blood components: implications for pharmacokinetics and for pharmacodynamics.

  1999cited by this paper
• Pharmacokinetics of thiopental enantiomers during and following prolonged high-dose therapy.

  1999cited by this paper
• The Influence of Method of Administration and Covariates on the Pharmacokinetics of Propofol in Adult Volunteers

  1998cited by this paper
• Pharmacodynamics and Pharmacokinetics of Thiopental

  1998cited by this paper
• Pharmacokinetics and pharmacodynamics of midazolam given via continuous intravenous infusion in intensive care units.

  1997cited by this paper
• Common molecular determinants of local anesthetic, antiarrhythmic, and anticonvulsant block of voltage-gated Na+ channels.

  1996cited by this paper
• Pharmacokinetic-Pharmacodynamic Relationships For Benzodiazepines

  1996cited by this paper
• Clinical Pharmacokinetics of Antiepileptic Drugs in Paediatric Patients

  1995cited by this paper
• Binding of fosphenytoin, phosphate ester pro drug of phenytoin, to human serum proteins and competitive binding with carbamazepine, diazepam, phenobarbital, phenylbutazone, phenytoin, valproic acid or warfarin.

  1995cited by this paper
• Digoxin Population Pharmacokinetics from Routine Clinical Data: Role of Patient Characteristics for Estimating Dosing Regimens

  1992cited by this paper
• Population pharmacokinetics and pharmacodynamics of thiopental: the effect of age revisited.

  1990cited by this paper
• Clinical Pharmacokinetics of Valproic Acid — 1988

  1988cited by this paper
• Brain uptake of benzodiazepines: effects of lipophilicity and plasma protein binding.

  1988cited by this paper
• Propofol infusion and green urine.

  1987cited by this paper
• Blood–Brain Barrier Transport of Valproic Acid

  1985cited by this paper
• In vitro correlates of benzodiazepine cerebrospinal fluid uptake, pharmacodynamic action and peripheral distribution.

  1983cited by this paper
• The Role of Metabolism and Protein Binding in Thiopental Anesthesia

  1983cited by this paper
• In vitro quantitation of benzodiazepine lipophilicity: relation to in vivo distribution.

  1983cited by this paper
• Concentration‐independent plasma protein binding of benzodiazepines

  1983cited by this paper
• Blood‐brain barrier transfer and cerebral uptake of antiepileptic drugs

  1982cited by this paper
• Phenytoin: blockage of resting sodium channels.

  1980cited by this paper
• Clinical Pharmacokinetics of Valproic Acid

  1980cited by this paper
• Pharmacokinetics of high-dose thiopental used in cerebral resuscitation.

  1980cited by this paper
• Metabolism of lorazepam.

  1976cited by this paper
• British Journal of Clinical Pharmacology Clinically Relevant Drug Interactions with Antiepileptic Drugs

  year unknowncited by this paper

• [Use of injectable lorazepam in status epilepticus: a comparative study in French-speaking hospitals].

  2010cites this paper